Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-183740
September 4, 2014
$175,000,000
HealthSouth Corporation
5.75% Senior Notes due 2024
| Issuer: | HealthSouth Corporation | |||
| Size: | $175,000,000 (Reopening of 2024 Notes issued on September 11, 2012) | |||
| Maturity: | November 1, 2024 | |||
| Coupon: | 5.75% | |||
| Offering Price: | 103.625% of face amount plus accrued interest from May 1, 2014 to the Settlement Date | |||
| Yield to Maturity: | 5.282% | |||
| Yield to Worst: | 5.053% | |||
| Interest Payment Dates: | May 1 and November 1 of each year, beginning on November 1, 2014 | |||
| Equity Clawback: | Up to 35% at 105.75% until November 1, 2015 | |||
| Optional Redemption: | Make-whole call at T+50 basis points to November 1, 2017, then: | |||
| On or after: | ||||
| November 1, 2017 | 102.875% | |||
| November 1, 2018 | 101.917% | |||
| November 1, 2019 | 100.958% | |||
| November 1, 2020 and thereafter | 100.000% | |||
| Underwriting Discount: | 1.75% | |||
| Net Proceeds to Issuer Before Expenses: | $178,281,250 | |||
| Trade Date: | September 4, 2014 | |||
| Settlement: | T+10; September 18, 2014 | |||
| Denomination: | $2,000, and integral multiples of $1,000 in excess thereof | |||
| CUSIP/ISIN: | CUSIP: 421924 BK6 | |||
| ISIN: US421924BK63 | ||||
| Ratings*: | Ba3/BB- (Moody’s/S&P) | |||
| Joint Book-Running Managers: | Barclays Capital Inc. | |||
| Citigroup Global Markets Inc. | ||||
| Goldman, Sachs & Co. | ||||
| J.P. Morgan Securities LLC | ||||
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | ||||
| Morgan Stanley & Co. Incorporated | ||||
| RBC Capital Markets, LLC | ||||
| SunTrust Robinson Humphrey, Inc. | ||||
| Wells Fargo Securities, LLC | ||||
| * | Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. |
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer or any underwriter will arrange to send you the prospectus if you request it by contacting any of the Joint Book-Running Managers at Barclays Capital Inc., (888) 603-5847, Citigroup Global Markets Inc., (877) 858-5407, Goldman, Sachs & Co., (866) 451-2526, J.P. Morgan Securities LLC, (800) 245-8812, Merrill Lynch, Pierce, Fenner & Smith Incorporated, (800) 294-1322, Morgan Stanley & Co. Incorporated, (212) 761-6217, RBC Capital Markets, LLC, (877) 280-1299, SunTrust Robinson Humphrey, Inc., (404) 926-5052 or Wells Fargo Securities, LLC, (800) 326-5897.
Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg email or another communication system.
-2-